Enquire Now

Innovator Drugs / Orphan Drugs

  • Home
  • Innovator Drugs / Orphan Drugs
Service Image

Supporting Breakthrough Therapies for Rare & Critical Conditions

Kleem Pharmaceuticals supports global partners in the development, sourcing, and supply of high-value innovator and orphan drugs designed to address rare diseases and critical therapeutic gaps.

Innovator drugs and orphan drugs represent the forefront of modern medicine, offering life-changing solutions for conditions with limited or no existing treatments. At Kleem Pharmaceuticals, we work with trusted research-driven facilities and regulatory experts to support the development, sourcing, and global supply of these specialized products.

Sr.No Product Dosage Strength Therapeutic Category
1 Valsartan Tablets 40, 80, 160, 320 mg Antihypertensive
2 Furosemide Tablets 20, 40, 80 mg Diuretic & Antihypertensive
3 Nitazoxanide Tablets 500 mg Antiprotozoal
4 Trientine Dihydrochloride Capsules 250, 300 mg Wilson's Disease
5 Sugammadex Sodium Injection Eq. 200 mg/2ml, 500 mg/5ml Base NMJ Reversal
6 Clozapine Tablets 25, 50, 100, 200 mg Antipsychotic
7 Vigabatrin Tablets 500 mg Antiepileptic
8 Tolvaptan (Jynarc) Tablets 15, 30, 45, 60, 90 mg ADPKD
9 Bilastine Tablets 20 mg Antiallergic
10 Eltrombopag Olamine Tablets Eq. 12.5, 25, 50, 75 mg Acid Thrombocytopenia
11 Nirmatrelvir + Ritonavir Tablets 150 + 100 mg Covid Antiviral
12 Nitisinone Capsules 2, 5, 10, 20 mg Hereditary Tyrosinemia

What Kleem Pharmaceuticals Offers

  • Global sourcing of rare and innovator molecules
  • Support for regulatory submissions & documentation
  • Collaboration with R&D partners for scale-up
  • Custom formulation and development support
  • Compliance with region-specific orphan drug guidelines
  • Export capability to 30+ international markets